Find the Basic Earnings Per Share and the Diluted Earnings Per Share.

Amy Dyken, controller at Fitzgerald Pharmaceutical Industries, a public company, is currently preparing the calculation for basic and diluted earnings per share and the related disclosure for Fitzgerald's financial statements. Below is selected financial Information for the fiscal year ended June 30, 2014. The following transactions have also occurred at Fitzgerald. Options were granted on July 1, 2013, to purchase 205,000 shares at dollar18 per share. Although no options were exercised during fiscal year 2014, the average price per common share during fiscal year 2014 was dollar30 per share. Each bond was issued at face value. The 8% convertible bonds will convert Into common stock at 55 shares per dollar1,000 bond. The bonds are exercisable after 5 years and were issued in fiscal year 2013. The preferred stock was issued in 2013. There are no preferred dividends In arrears; however, preferred dividends were not declared in fiscal year 2014. The 1,015,400 shares of common stock were outstanding for the entire 2014 fiscal year. Net Income for fiscal year 2014 was dollar1,526,000, and the average income tax rate is 45%